124 related articles for article (PubMed ID: 4698954)
21. [Anti-measles vaccination with the Schwarz hyperattenuated live vaccine; post-vaccinal virological study and serological examination for 2 years].
Boué A; Celers J
Pathol Biol; 1967 Jan; 15(1):65-70. PubMed ID: 5340408
[No Abstract] [Full Text] [Related]
22. Localization of measles antibody and inhibitor activity in fractions of human sera at different stages of the disease, and sera of animals immunized with measles virus. I. Dynamics of increase in measles antibody activity and its localization in children sera after natural infection.
Polna I; Aleksandrowicz J; Roszkowska K
Acta Microbiol Pol A; 1973; 5(3):131-8. PubMed ID: 4203632
[No Abstract] [Full Text] [Related]
23. [Use of the IgM fraction from patients' sera in general virus serology for diagnostic purposes].
Wolff MH; Marklein G; Schneweis KE; Stifter G
Zentralbl Bakteriol Orig A; 1974; 227(1-4):392-400. PubMed ID: 4154618
[No Abstract] [Full Text] [Related]
24. Hospital-associated measles outbreak - Pennsylvania, March-April 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Jan; 61(2):30-2. PubMed ID: 22258416
[TBL] [Abstract][Full Text] [Related]
25. Development and evaluation of the Moraten measles virus vaccine.
Hilleman MR; Buynak EB; Weibel RE; Stokes J; Whitman JE; Leagus MB
JAMA; 1968 Oct; 206(3):587-90. PubMed ID: 5695578
[No Abstract] [Full Text] [Related]
26. Clinical epidemiology of sporadic measles in a highly immunized population.
Schaffner W; Schluederberg AE; Byrne EB
N Engl J Med; 1968 Oct; 279(15):783-9. PubMed ID: 5676221
[No Abstract] [Full Text] [Related]
27. Antibody response and clinical reactions in children given measles vaccine with immunoglobulin.
Lingam S; Miller CL; Clarke M; Pateman J
Br Med J (Clin Res Ed); 1986 Apr; 292(6527):1044-5. PubMed ID: 3083994
[TBL] [Abstract][Full Text] [Related]
28. [Indices of humoral antimeasles postvaccinal immunity].
Tikhonova NT; Prokudina IuA; Khrometskaia TM; Potemkina EE
Vopr Virusol; 1975; (3):287-92. PubMed ID: 1162947
[TBL] [Abstract][Full Text] [Related]
29. [Comparative results of anti-measles serological immunity after the disease and after vaccination].
Topciu V; Moldovan E; Csaky N; Băcilă E
Arch Roum Pathol Exp Microbiol; 1970 Dec; 29(4):671-5. PubMed ID: 5521121
[No Abstract] [Full Text] [Related]
30. [The distribution of measles antibodies among different classes of immunoglobulins].
Tikhonova NT; Khrometskaia TM; Kholchev NV; Strel'tsova MP; Ignat'eva GV
Zh Mikrobiol Epidemiol Immunobiol; 1973 Jun; 50(6):27-33. PubMed ID: 4780909
[No Abstract] [Full Text] [Related]
31. [Atypical measles experienced in 1970].
Seki T; Hara M; Miyazaki Y; Chiba H; Yokota K
Nihon Shonika Gakkai Zasshi; 1971 Jun; 75(6):440-5. PubMed ID: 5104630
[No Abstract] [Full Text] [Related]
32. [Activities of immune globulins at the time of measles vaccine inoculation and measles infection, with special reference to sensitivity and resistance of the antibody to 2-mercaptoethanol].
Arai M; Nakamura M
Nihon Shonika Gakkai Zasshi; 1969 Dec; 73(12):2032-7. PubMed ID: 4191839
[No Abstract] [Full Text] [Related]
33. A comparison of Edmonston-B and Schwarz measles vaccine in Malian children.
Jean-Joseph P; Sow S; Casey HL; Imperato PJ; Henderson RH; Noble J
Lancet; 1969 Mar; 1(7596):665-7. PubMed ID: 4179897
[No Abstract] [Full Text] [Related]
34. Atypical measles. Severe illness in recipients of killed measles virus vaccine upon exposure to natural infection.
Brodsky AL
JAMA; 1972 Dec; 222(11):1415-6. PubMed ID: 4678322
[No Abstract] [Full Text] [Related]
35. Comparative trial of further attenuated measles vaccines.
Hendrickse RG; Montefiore D; Sherman P; Peradze T
Br Med J; 1966 Mar; 1(5490):779-81. PubMed ID: 5910109
[No Abstract] [Full Text] [Related]
36. [State of humoral immunity in measles (hemagglutination inhibition test data)].
Bystriakova LV; Truskova NIa; Shikina ES
Zh Mikrobiol Epidemiol Immunobiol; 1971 Sep; 48():12-4. PubMed ID: 4107078
[No Abstract] [Full Text] [Related]
37. Measles in children previously vaccinated against measles.
Lerman SJ; Gold E
JAMA; 1971 May; 216(8):1311-4. PubMed ID: 4102807
[No Abstract] [Full Text] [Related]
38. Studies on further attenuated live measles vaccine. IV. Clinical and serological evaluation of a clone of CAM-CEF measles vaccine virus.
Ueda S; Takahashi M; Kurimura T; Ogino T; Suzuki N
Biken J; 1970 Sep; 13(3):169-74. PubMed ID: 5530511
[No Abstract] [Full Text] [Related]
39. Studies on further attenuated live measles vaccine. V. Immunization test of CAM-A4 measles vaccine on handicapped children.
Ueda S; Okuno Y; Sakamoto Y
Biken J; 1970 Sep; 13(3):175-8. PubMed ID: 4249672
[No Abstract] [Full Text] [Related]
40. Haemagglutination inhibition antibody levels one year after natural measles infection and vaccination.
Eghafona NO; Ahmad AA; Ezeokoli CD; Emejuaiwe SO
Microbios; 1991; 67(274):33-6. PubMed ID: 1758308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
